Silicone breast implants were pulled off the market in 1992 amid concerns that leaks from the implants could lead to cancer or autoimmune disease. Five years ago, revamped products returned to the ...

Jan. 10, 2007 — -- When the Food and Drug Administration lifted the 14-year moratorium on silicone breast implants in mid-November, many believed that the move would have women rushing to their ...

When it comes to breast augmentation, which involves breast implants, there are actually two types to choose from: saline and silicone. While they achieve a similar look and are both approved by the ...

The longer silicone implants in, the more likely there'll be complications. June 22, 2011— -- Silicone gel-filled implants are not lifetime devices, and the longer they're in the body, the more ...

There are two general types of breast implants available in the U.S. -- saline and silicone gel. Both consist of a silicone outer shell; the difference is what's inside the implants. Saline implants ...

Silicone breast implants have made a big comeback in cosmetic procedures, a little more than six years after the U.S. Food and Drug Administration lifted its ban on most use of the devices. In 2012, ...

One month after the FDA approved the return of silicone gel-filled breast implants to the U.S. market, a European study is raising new concerns about their safety. Researchers in Austria have ...

Good evidence on the safety of silicone gel breast implants is still lacking almost 10 years after they were reintroduced to the U.S. market, researchers report in the Annals of Internal Medicine.

Thicker shells and stickier silicone make today's silicone-gel breast implants less prone to break and leak than versions sold years ago, Inamed Corp. argued Tuesday in asking the government to end a ...

Silicone implants can increase a woman's risk of arthritis, stillbirth and even skin cancer, a new study suggests. Researchers found that women had a 4.5-fold increased risk of having a stillbirth and ...

Silicone gel implants were taken off the market in 1992 amidst fears that they could be linked to cancer, autoimmune and connective tissue disorders (such as lupus). But since the FDA approved their ...